We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PANW icon
226
Palo Alto Networks
PANW
$329B
$1.99M 0.04%
+17,000
New +$2.01M
2023 Q3
0 quarters
FRBN
227
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$1.99M 0.04%
181,263
– –
2022 Q2
5 quarters
WEL icon
228
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.99M 0.04%
181,263
– –
2022 Q1
6 quarters
CSCO icon
229
Cisco
CSCO
$454B
$1.96M 0.03%
+36,506
New +$1.97M
2023 Q3
0 quarters
MTCH icon
230
Match Group
MTCH
$9.55B
$1.96M 0.03%
50,000
+25,000
+100% +$1.11M
2023 Q1
2 quarters
ESTA icon
231
Establishment Labs
ESTA
$1.81B
$1.96M 0.03%
39,902
+3,000
+8% +$179K
2022 Q1
6 quarters
DCPH icon
232
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.96M 0.03%
153,737
+77,000
+100% +$1.06M
2022 Q3
4 quarters
MIRM icon
233
Mirum Pharmaceuticals
MIRM
$5.57B
$1.93M 0.03%
61,000
+37,000
+154% +$1.01M
2023 Q2
1 quarter
KROS icon
234
Keros Therapeutics
KROS
$236M
$1.92M 0.03%
60,341
+5,000
+9% +$187K
2022 Q1
6 quarters
ROIV icon
235
Roivant Sciences
ROIV
$25.3B
$1.92M 0.03%
164,211
-26,000
-14% -$294K
2022 Q4
3 quarters
TAL icon
236
TAL Education Group
TAL
$7.14B
$1.92M 0.03%
+210,317
New +$1.47M
2023 Q3
0 quarters
MTZ icon
237
MasTec
MTZ
$16.6B
$1.89M 0.03%
26,295
+4,300
+20% +$429K
2023 Q2
1 quarter
TEVA icon
238
Teva Pharmaceutical Industries Limited
TEVA
$48B
$1.89M 0.03%
+185,000
New +$1.72M
2023 Q3
0 quarters
NFYS icon
239
DELISTED
Enphys Acquisition Corp.
NFYS
$1.87M 0.03%
178,033
– –
2022 Q2
5 quarters
HOLI icon
240
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$1.86M 0.03%
+93,570
New +$1.69M
2023 Q3
0 quarters
KNSA icon
241
Kiniksa Pharmaceuticals
KNSA
$6.26B
$1.85M 0.03%
106,423
-115,000
-52% -$1.94M
2022 Q3
4 quarters
MGM icon
242
MGM Resorts International
MGM
$7.32B
$1.82M 0.03%
49,500
-359,902
-88% -$15.9M
2023 Q1
2 quarters
KIDS icon
243
OrthoPediatrics
KIDS
$570M
$1.8M 0.03%
56,219
+11,000
+24% +$424K
2022 Q1
6 quarters
AXSM icon
244
Axsome Therapeutics
AXSM
$8.79B
$1.8M 0.03%
25,735
– –
2022 Q1
6 quarters
RCUS icon
245
Arcus Biosciences
RCUS
$3.11B
$1.78M 0.03%
99,412
-5,000
-5% -$100K
2022 Q2
5 quarters
TCOM icon
246
Trip.com Group
TCOM
$24.3B
$1.75M 0.03%
50,000
-7,500
-13% -$282K
2023 Q2
1 quarter
BCRX icon
247
BioCryst Pharmaceuticals
BCRX
$2.12B
$1.71M 0.03%
241,820
+9,357
+4% +$67.2K
2022 Q1
6 quarters
XFOR icon
248
X4 Pharmaceuticals
XFOR
$286M
$1.7M 0.03%
52,000
+37,000
+247% +$1.61M
2023 Q2
1 quarter
PATH icon
249
UiPath
PATH
$6.86B
$1.67M 0.03%
+97,500
New +$1.62M
2023 Q3
0 quarters
XENE icon
250
Xenon Pharmaceuticals
XENE
$3.49B
$1.66M 0.03%
48,676
+10,000
+26% +$374K
2022 Q1
6 quarters
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.